Drawing for SGEN

USPTO serial 97017710

SGEN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
LATTUCA, FRANK J
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

YUE (ROBERT) XU

YUE (ROBERT) XU APEX ATTORNEYS AT LAW, LLP160 ALAMO PLAZA #942ALAMO, CA 94507UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Human vaccine preparations; Antibiotics for human use; Dietary supplements for human consumption; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Radioactive substances for medical purposes; Gases for medical and dental use; Gases and gas mixtures for medical imaging use; Cartridges sold pre-filled with gases and gas mixtures for medical use; Disinfectants; Bacteriological culture mediums; Dietetic foods adapted for medical purposes; Surgical dressings; All containing in whole or significant part, gene therapy substancesABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2023MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Apr 25, 2023ABN4ABANDONMENT - AFTER INTER PARTES DECISION
Apr 25, 2023OP.TOPPOSITION TERMINATED NO. 999999
Apr 25, 2023OP.SOPPOSITION SUSTAINED NO. 999999
Nov 16, 2022OP.IOPPOSITION INSTITUTED NO. 999999
Aug 11, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jul 19, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2022DOCKASSIGNED TO EXAMINER
Oct 18, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance